Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:epoetin_alfa
|
| gptkbp:administeredBy |
injection
|
| gptkbp:approvedBy |
gptkb:European_Medicines_Agency
1990s |
| gptkbp:ATCCode |
B03XA01
|
| gptkbp:brand |
gptkb:epoetin_alfa
|
| gptkbp:contraindication |
uncontrolled hypertension
hypersensitivity to epoetin alfa |
| gptkbp:form |
solution for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Eprex
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
gptkb:Janssen
|
| gptkbp:routeOfAdministration |
subcutaneous
intravenous |
| gptkbp:sideEffect |
hypertension
thromboembolism flu-like symptoms |
| gptkbp:usedFor |
gptkb:anemia
chronic kidney disease chemotherapy-induced anemia |
| gptkbp:bfsParent |
gptkb:epoetin_alfa
gptkb:Epogen |
| gptkbp:bfsLayer |
7
|